NRP1 and glioblastoma: As shown in S7 Fig, silencing Nrp1 in GBM cells leads to a reduction in TGFβ receptor signaling, as determined by quantifying levels of phosphorylated Smad3 (pSmad3) protein following treatment with TGFβ1.